About Selborne
The widespread use of tissue cultures in the production of
viral vaccines during the 1960’s brought to the fore
the need for high quality serum as a component of cell culture
medium. Based at a 100 acre isolation farm in Hampshire, England,
a company was formed in the spring of 1974 to fill this need.
From that beginning, Selborne Biological Services Ltd. (Selborne)
has grown to become a leading specialist in the production
of blood-based products, protein fractions, custom polyclonals
and other animal related products and services for the biotech,
pharmaceutical, diagnostic and veterinary industries.
In the late 1980’s, the outbreak of Bovine Spongiform
Encephalopathy (BSE), combined with Sheep Scrapie disease
in the United Kingdom posed significant problems for manufacturers
of biological medicines utilizing serum. This realisation
prompted Selborne to turn their attention to the Southern
Hemisphere, to countries known to be free of BSE and Sheep
Scrapie. Australia and New Zealand were ideal, having economies
based heavily on agriculture, an animal health status which
was excellent, and importation of animals strictly monitored.
Operations were quickly established at Tauranga, New Zealand,
followed in 1992 by a manufacturing site in Tasmania, Australia.
In 1997, Selborne sold the Tauranga site to focus its manufacturing
operations in Tasmania. Conditions on the island of Tasmania
were ideal for a biological based operation since it is an
isolated location some 150 miles south of the Australian mainland
across the Bass Strait. This facility was expanded in 1998
and is now the main manufacturing site for Selborne’s
global operations. This facility has production capabilities
for a variety of serums and proteins, including significant
large animal facilities for the production of custom polyclonal
antiserums.
In 2005, Selborne continued its expansion through the formation
of a USA affilliate based in Logan, Utah. The US office serves
as the global center for Selborne's Sales and Marketing activities.
The UK facility continues to produce immunoglobulin products
from a wide variety of animal species as well as performing
sales and administrative functions.
Mission Statement
Contact Selborne
Offices & Facilities
Custom Manufacturing
QA/QC
|
